Literature DB >> 26449932

A ROS-mediated lysosomal-mitochondrial pathway is induced by ginsenoside Rh2 in hepatoma HepG2 cells.

Fang Chen1, ZeYuan Deng1, ZengXing Xiong1, Bing Zhang2, JianYuan Yang3, JiangNing Hu1.   

Abstract

Ginsenoside Rh2 (GRh2), isolated from Panax ginseng C. A. Meyer, has been proven as an anticancer compound both in vitro and in vivo. In the present study, we investigated the role of the lysosomes during the apoptosis of HepG2 cells induced by GRh2. The results showed that GRh2 significantly induced intracellular reactive oxygen species (ROS) generation in the HepG2 cells, which consequently resulted in early lysosomal membrane permeabilization with the release of cathepsin B (Cat B) to the cytosol. Western blot analysis showed that the released Cat B in the cytosol contributed to Bid cleavage. Subsequently mitochondrial damage was observed in the HepG2 cells. Interestingly, when the HepG2 cells were pre-treated with N-Acetyl-L-Cysteine (NAC) for 1 h, which inhibited ROS generation before being exposed to GRh2, the permeabilization of lysosomal membranes and the levels of Cat B in the cytosol were down-regulated. Moreover, mitochondrial damage was alleviated when the HepG2 cells were pre-treated with leupeptin (Leu). From the above results, it could be concluded that GRh2 induced apoptosis of the HepG2 cells through accumulation of ROS and activation of the lysosomal-mitochondrial apoptotic pathway involving the release of Cat B.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26449932     DOI: 10.1039/c5fo00518c

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  8 in total

1.  The effect of A2E on lysosome membrane permeability during blue light-induced human RPEs apoptosis.

Authors:  Yan Xu; Dan Li; Gang Su; Shanjun Cai
Journal:  BMC Ophthalmol       Date:  2022-05-31       Impact factor: 2.086

2.  9c11tCLA modulates 11t18:1 and 9t18:1 induced inflammations differently in human umbilical vein endothelial cells.

Authors:  Jing Li; Sheng-Ben Hu; Yue-Ming He; Cheng-Fei Zhuo; Ruo-Lin Zhou; Fang Chen; Hong-Yan Li; Ze-Yuan Deng
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

3.  Heat stress induces intestinal injury through lysosome- and mitochondria-dependent pathway in vivo and in vitro.

Authors:  Gao Yi; Li Li; Meijuan Luo; Xuan He; Zhimin Zou; Zhengtao Gu; Lei Su
Journal:  Oncotarget       Date:  2017-06-20

Review 4.  Diet-induced obesity in animal models: points to consider and influence on metabolic markers.

Authors:  Mariana de Moura E Dias; Sandra Aparecida Dos Reis; Lisiane Lopes da Conceição; Catarina Maria Nogueira de Oliveira Sediyama; Solange Silveira Pereira; Leandro Licursi de Oliveira; Maria do Carmo Gouveia Peluzio; J Alfredo Martinez; Fermín Ignacio Milagro
Journal:  Diabetol Metab Syndr       Date:  2021-03-18       Impact factor: 3.320

5.  20(S)-ginsenoside Rh2 induces caspase-dependent promyelocytic leukemia-retinoic acid receptor A degradation in NB4 cells via Akt/Bax/caspase9 and TNF-α/caspase8 signaling cascades.

Authors:  Sirui Zhu; Xiaoli Liu; Mei Xue; Yu Li; Danhong Cai; Shijun Wang; Liang Zhang
Journal:  J Ginseng Res       Date:  2020-05-15       Impact factor: 6.060

6.  Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex.

Authors:  Ying Liu; Shiting Yu; Xin Xing; Juhui Qiao; Yiqiu Yin; Jiawen Wang; Meichen Liu; Wei Zhang
Journal:  Mol Med Rep       Date:  2021-10-29       Impact factor: 2.952

7.  The Octyl Ester of Ginsenoside Rh2 Induces Lysosomal Membrane Permeabilization via Bax Translocation.

Authors:  Fang Chen; Bing Zhang; Yong Sun; Zeng-Xing Xiong; Han Peng; Ze-Yuan Deng; Jiang-Ning Hu
Journal:  Nutrients       Date:  2016-04-25       Impact factor: 5.717

Review 8.  Role of ginsenosides in reactive oxygen species-mediated anticancer therapy.

Authors:  Islam M D Sodrul; Chenying Wang; Xiangfeng Chen; Jing Du; Hongxiang Sun
Journal:  Oncotarget       Date:  2017-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.